A sorbet-filled mochi recalled due to an undeclared allergen has been given the U.S. Food and Drug Administration (FDA)'s highest risk level. The My Mochi Ice Cream Company of Vernon, California, recalled 1,
Aaron Siri, a lawyer advising Robert F. Kennedy Jr. as he prepared to become health secretary, petitioned the Food and Drug Administration in 2022 to revoke approval of a polio vaccine that is used widely in the U.
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 profit
Broccoli packages sold at Walmart stores in 20 states have received an elevated recall status over a Listeria contamination that has potentially fatal consequences.
The FDA classified the recall of Lay's Classic Potato Chips in Oregon and Washington state as a Class 1 recall, which means consumption could be fatal for people with a milk allergy.
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence that GLP-1 drugs improve overall health along with weight loss.
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco harm
NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy treatment market with its Responsive Neurostimulation (RNS) System.
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory approval. ... Read More The post Phase III Trials: It’s crunch time for these ASX health stocks appeared first on Stockhead.